Patents Assigned to Bio Logicals Inc.
  • Patent number: 4501744
    Abstract: Nucleoside analogues having a ring-open structure, of general formula: ##STR1## where R and R' may be hydrogen, silyl groups, substituted alkyl groups, benzyl groups and the like, and X is an optionally substituted pyrimidine or triazine base, exhibit anti-viral activities e.g. against herpes simplex virus and cytomegalo-virus at non-toxic levels.
    Type: Grant
    Filed: July 28, 1983
    Date of Patent: February 26, 1985
    Assignee: ens BIO LOGICALS Inc.
    Inventor: Kelvin K. Ogilvie
  • Patent number: 4462986
    Abstract: Combinations of 9-[[2-hydroxy-1-(hydroxymethyl)-ethoxy]methyl]guanine or a pharmaceutically acceptable salt thereof, and interferon show synergy in their activity against herpes virus infections.
    Type: Grant
    Filed: November 4, 1982
    Date of Patent: July 31, 1984
    Assignee: Ens Bio Logicals, Inc.
    Inventor: Kendall O. Smith
  • Patent number: 4461757
    Abstract: 2-(N,N-dialkylaminomethylene)-9-[[2-hydroxy-1-(hydroxymethyl)-ethoxy]methyl ]guanine either alone or in admixture with interferon is active in treatment of herpes simplex type 1 viral infections.
    Type: Grant
    Filed: February 23, 1983
    Date of Patent: July 24, 1984
    Assignee: ens Bio Logicals Inc.
    Inventor: Kelvin K. Ogilvie
  • Patent number: 4460690
    Abstract: The novel nucleoside analogue 9-[1-(1,3-diacetoxy-2-propoxy)-2-acetoxy]ethylguanine has the effect of stimulating the rate of growth of certain viruses, particularly influenza viruses, so that culturing virally infected cells in the presence of this compound substantially decreases the time required for diagnosis and typing of the virus, ready for administration of appropriate anti viral measures.
    Type: Grant
    Filed: February 18, 1983
    Date of Patent: July 17, 1984
    Assignee: ens Bio Logicals inc.
    Inventor: Kelvin K. Ogilvie
  • Patent number: 4353989
    Abstract: An apparatus for the stepwise synthesis of polynucleotides in which the polynucleotide chains are extended in stepwise fashion from a modified form of polymer support to which the first unit is linked comprises a reaction column containing the polymer supported product and acting as the reaction vessel, and a series of reaction bottles all connected to the reaction column by means of a fluid flow conduit to which the vessels make connection via two-way valves arranged in series. The farthest upstream vessel of the series contains reaction solvent, used for washing purposes and the like. The most downstream of the reaction vessels contain nucleotide reagents.
    Type: Grant
    Filed: January 19, 1981
    Date of Patent: October 12, 1982
    Assignee: ens Bio Logicals Inc.
    Inventors: Robert Bender, Peter D. Duck
  • Patent number: 4347360
    Abstract: Nucleoside analogues having a ring-open structure, of general formula: ##STR1## where R and R' may be hydrogen, silyl groups, substituted alkyl groups and the like, and B is a base such as adenine, have been shown to exhibit anti-viral and other biological activities at non-toxic levels. Also provided are phosphate-linked dinucleotide compounds of similar structures.
    Type: Grant
    Filed: September 16, 1980
    Date of Patent: August 31, 1982
    Assignee: ens BIO LOGICALS Inc.
    Inventor: Kelvin K. Ogilvie
  • Patent number: 4334059
    Abstract: Silylated arabino-base compounds of the general formula: ##STR1## in which B represents an optionally substituted purine or pyrimidine base (cytosine, guanine, uracil, thymine or adenine) and one at least of R, R' and R" is alkylsilyl, the others being hydrogen, show activity as antiviral agents, especially in combatting herpes simplex virus. The preferred alkylsilyl group is tert. butyldimethylsilyl.
    Type: Grant
    Filed: October 20, 1980
    Date of Patent: June 8, 1982
    Assignee: Bio Logicals Inc.
    Inventor: Kelvin K. Ogilvie